1 recruiting, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 1, Unknown 1 |
Follow Arrythmia: new trials by email Literature Review of Arrythmia trials Research Report on Arrythmia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients Intra-Op Prophylactic VT ablation, Conventional Management - Arrythmia, Cardiomyopathies | Phase 4 | Recruiting | University of Rochester | 100 | 2022-05-27 | 2026-07-14 |
| Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients Empagliflozin at a dose of 10 mg/day - Heart Failure, Diabetes Mellitus | Phase 4 | Unknown | Rambam Health Care Campus | 128 | 2018-02-15 | 2018-01-25 |
Arrhythmias, Cardiac (2) · Cardiomyopathies (1) · Diabetes Mellitus (1) · Heart Failure (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Rambam Health Care Campus (1) · University of Rochester (1)
United States (1)
David Huang, MD (1) · Oren Caspi, MD (1)
R01HL159401 (1)